home All News open_in_new Full Article

Mounjaro (Lilly) desbancará a Keytruda (MSD) como el medicamento más vendido en el año 2030

La compañía colocará otra terapia entre las tres más vendidas dentro de cinco años. Más información: Lilly adquiere Verve Therapeutics por hasta 1.300 millones de dólares


today 3 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 857142329
Add Watch Country

arrow_drop_down